The proportion of the effects of genetically-predicted psoriasis mediated through genetically-predicted ESMA and IL-16 was 24.8% (95% CI 8.3%–41.2%) and 16.1% (95% CI 5.3%–26.8%), respectively. The gene discussed is IL16; the disease is psoriasis.